Global Alzheimer’s Therapeutic Market Research Report 2020

July 2016 | 106 pages | ID: GCB69377BE5EN
QYResearch

Abstracts

This report studies Alzheimer’s Therapeutic in Global market, especially in North America, Europe, China, Japan, India and Southeast Asia, focuses on top manufacturers in global market, with sales, price, revenue and market share for each manufacturer, covering

• Pfizer Inc
• Novartis International AG
• Axovant Sciences Ltd
• Acadia Pharmaceuticals, Inc
• Biotie Therapies
• Astra Zeneca plc
• Eli Lilly, Inc
• F. Hoffman Le Roche
• Merck & Co
• H. Lundbeck A/S
• Takeda Pharmaceutical Company Ltd

Market Segment by Region, this report splits Global into several key Regions, with sales, revenue, market share and growth rate of Alzheimer’s Therapeutic in these regions, from 2011 to 2021 (forecast), like

• North America
• China
• Europe
• Japan
• India
• Southeast Asia

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Memantine Hydrochloride
• Donepezil Hydrochloride
• Rivastigmine
• Galantamine Hydrobromide

Split by application, this report focuses on sales, market share and growth rate of Alzheimer’s Therapeutic in each application, can be divided into

• Hospitals
• Clinic
• Other

Contents

Global Alzheimer’s Therapeutic Market Research Report 2021

1 ALZHEIMER’S THERAPEUTIC OVERVIEW

1.1 Product Overview and Scope of Alzheimer’s Therapeutic
1.2 Alzheimer’s Therapeutic Segment by Types
  1.2.1 Global Sales Market Share of Alzheimer’s Therapeutic by Type in 2015
  1.2.2 Memantine Hydrochloride
  1.2.3 Donepezil Hydrochloride
  1.2.4 Rivastigmine
  1.2.5 Galantamine Hydrobromide
1.3 Alzheimer’s Therapeutic Segment by Applications
  1.3.1 Hospitals
  1.3.2 Clinic
  1.3.3 Other
1.4 Alzheimer’s Therapeutic Market by Regions
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 India Status and Prospect (2011-2021)
  1.4.6 Southeast Asia Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Alzheimer’s Therapeutic (2011-2021)
  1.5.1 Global Alzheimer’s Therapeutic Sales and Revenue (2011-2021)
  1.5.2 Global Alzheimer’s Therapeutic Sales and Growth Rate (2011-2021)
  1.5.3 Global Alzheimer’s Therapeutic Revenue and Growth Rate (2011-2021)

2 GLOBAL ALZHEIMER’S THERAPEUTIC MARKET COMPETITION BY MANUFACTURERS

2.1 Global Alzheimer’s Therapeutic Sales and Share by Manufacturers (2015 and 2016)
2.2 Global Alzheimer’s Therapeutic Revenue and Share by Manufacturers (2015 and 2016)
2.3 Manufacturers Alzheimer’s Therapeutic Manufacturing Base Distribution and Product Type
2.4 Competitive Situation and Trends
  2.4.1 Expansions
  2.4.2 New Product Launches
  2.4.3 Acquisitions
  2.4.4 Other Developments

3 GLOBAL ALZHEIMER’S THERAPEUTIC ANALYSIS BY REGION

3.1 Global Alzheimer’s Therapeutic Sales, Revenue and Market Share by Region (2011-2021)
  3.1.1 Global Alzheimer’s Therapeutic Sales Market Share by Region (2011-2021)
  3.1.2 Global Alzheimer’s Therapeutic Revenue Market Share by Region (2011-2021)
3.2 North America
  3.2.1 North America Alzheimer’s Therapeutic Sales, Revenue and Price (2011-2021)
  3.2.2 North America Alzheimer’s Therapeutic Sales, Revenue and Growth Rate (2011-2021)
3.3 Europe
  3.3.1 Europe Alzheimer’s Therapeutic Sales, Revenue and Price (2011-2021)
  3.3.2 Europe Alzheimer’s Therapeutic Sales, Revenue and Growth Rate (2011-2021)
3.4 China
  3.4.1 China Alzheimer’s Therapeutic Sales, Revenue and Price (2011-2021)
  3.4.2 China Alzheimer’s Therapeutic Sales, Revenue and Growth Rate (2011-2021)
3.5 Japan
  3.5.1 Japan Alzheimer’s Therapeutic Sales, Revenue and Price (2011-2021)
  3.5.2 Japan Alzheimer’s Therapeutic Sales, Revenue and Growth Rate (2011-2021)
3.6 India
  3.6.1 India Alzheimer’s Therapeutic Sales, Revenue and Price (2011-2021)
  3.6.2 India Alzheimer’s Therapeutic Sales, Revenue and Growth Rate (2011-2021)
3.7 Southeast Asia
  3.7.1 Southeast Asia Alzheimer’s Therapeutic Sales, Revenue and Price (2011-2021)
  3.7.2 Southeast Asia Alzheimer’s Therapeutic Sales, Revenue and Growth Rate (2011-2021)

4 GLOBAL ALZHEIMER’S THERAPEUTIC ANALYSIS BY TYPE

4.1 Global Alzheimer’s Therapeutic Sales, Revenue, Market Share and Growth Rate by Type (2011-2021)
  4.1.1 Global Alzheimer’s Therapeutic Sales and Market Share by Type (2011-2021)
  4.1.2 Global Alzheimer’s Therapeutic Revenue, Market Share and Growth Rate by Type (2011-2021)
4.2 Memantine Hydrochloride Sales, Revenue, Price and Growth (2011-2021)
4.3 Donepezil Hydrochloride Sales, Revenue, Price and Growth (2011-2021)
4.4 Rivastigmine Sales, Revenue, Price and Growth (2011-2021)
4.5 Galantamine Hydrobromide Sales, Revenue, Price and Growth (2011-2021)

5 GLOBAL ALZHEIMER’S THERAPEUTIC MARKET ANALYSIS BY APPLICATION

5.1 Global Alzheimer’s Therapeutic Sales and Market Share by Application (2011-2021)
5.2 Major Regions Alzheimer’s Therapeutic Sales by Application in 2015 and 2016
  5.2.1 North America Alzheimer’s Therapeutic Sales by Application
  5.2.2 Europe Alzheimer’s Therapeutic Sales by Application
  5.2.3 China Alzheimer’s Therapeutic Sales by Application
  5.2.4 Japan Alzheimer’s Therapeutic Sales by Application
  5.2.5 India Alzheimer’s Therapeutic Sales by Application
  5.2.6 Southeast Asia Alzheimer’s Therapeutic Sales by Application

6 GLOBAL ALZHEIMER’S THERAPEUTIC MANUFACTURERS ANALYSIS

6.1 Pfizer Inc
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Alzheimer’s Therapeutic Product Overview
    6.1.2.1 Memantine Hydrochloride
    6.1.2.2 Donepezil Hydrochloride
    6.1.2.3 Rivastigmine
  6.1.3 Alzheimer’s Therapeutic Sales, Revenue, Price of Pfizer Inc (2015 and 2016)
6.2 Novartis International AG
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Alzheimer’s Therapeutic Product Overview
    6.2.2.1 Memantine Hydrochloride
    6.2.2.2 Donepezil Hydrochloride
    6.2.2.3 Rivastigmine
  6.2.3 Alzheimer’s Therapeutic Sales, Revenue, Price of Novartis International AG (2015 and 2016)
6.3 Axovant Sciences Ltd
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Alzheimer’s Therapeutic Product Overview
    6.3.2.1 Memantine Hydrochloride
    6.3.2.2 Donepezil Hydrochloride
    6.3.2.3 Rivastigmine
  6.3.3 Alzheimer’s Therapeutic Sales, Revenue, Price of Axovant Sciences Ltd (2015 and 2016)
6.4 Acadia Pharmaceuticals, Inc
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Alzheimer’s Therapeutic Product Overview
    6.4.2.1 Memantine Hydrochloride
    6.4.2.2 Donepezil Hydrochloride
  6.4.3 Alzheimer’s Therapeutic Sales, Revenue, Price of Acadia Pharmaceuticals, Inc (2015 and 2016)
6.5 Biotie Therapies
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Alzheimer’s Therapeutic Product Overview
    6.5.2.1 Memantine Hydrochloride
    6.5.2.2 Donepezil Hydrochloride
  6.5.3 Alzheimer’s Therapeutic Sales, Revenue, Price of Biotie Therapies (2015 and 2016)
6.6 Astra Zeneca plc
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Alzheimer’s Therapeutic Product Overview
    6.6.2.1 Memantine Hydrochloride
    6.6.2.2 Donepezil Hydrochloride
  6.6.3 Alzheimer’s Therapeutic Sales, Revenue, Price of Astra Zeneca plc (2015 and 2016)
6.7 Eli Lilly, Inc
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Alzheimer’s Therapeutic Product Overview
    6.7.2.1 Memantine Hydrochloride
    6.7.2.2 Donepezil Hydrochloride
  6.7.3 Alzheimer’s Therapeutic Sales, Revenue, Price of Eli Lilly, Inc (2015 and 2016)
6.8 F. Hoffman Le Roche
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Alzheimer’s Therapeutic Product Overview
    6.8.2.1 Memantine Hydrochloride
    6.8.2.2 Donepezil Hydrochloride
  6.8.3 Alzheimer’s Therapeutic Sales, Revenue, Price of F. Hoffman Le Roche (2015 and 2016)
6.9 Merck & Co
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Alzheimer’s Therapeutic Product Overview
    6.9.2.1 Memantine Hydrochloride
    6.9.2.2 Donepezil Hydrochloride
  6.9.3 Alzheimer’s Therapeutic Sales, Revenue, Price of Merck & Co (2015 and 2016)
6.10 H. Lundbeck A/S
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Alzheimer’s Therapeutic Product Overview
    6.10.2.1 Memantine Hydrochloride
    6.10.2.2 Donepezil Hydrochloride
  6.10.3 Alzheimer’s Therapeutic Sales, Revenue, Price of H. Lundbeck A/S (2015 and 2016)
6.11 Takeda Pharmaceutical Company Ltd

7 INDUSTRY POLICY ANALYSIS

8 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Alzheimer’s Therapeutic
Figure Global Sales Market Share of Alzheimer’s Therapeutic by Type in 2015
Table Alzheimer’s Therapeutic Product Type of by Manufacturers
Table Alzheimer’s Therapeutic Sales Market Share by Application in 2015 and 2016
Figure North America Alzheimer’s Therapeutic Revenue and Growth Rate (2011-2021)
Figure China Alzheimer’s Therapeutic Revenue and Growth Rate (2011-2021)
Figure Europe Alzheimer’s Therapeutic Revenue and Growth Rate (2011-2021)
Figure Japan Alzheimer’s Therapeutic Revenue and Growth Rate (2011-2021)
Figure India Alzheimer’s Therapeutic Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Alzheimer’s Therapeutic Revenue and Growth Rate (2011-2021)
Table Global Alzheimer’s Therapeutic Sales and Revenue (2011-2021)
Figure Global Alzheimer’s Therapeutic Sales and Growth Rate (2011-2021)
Figure Global Alzheimer’s Therapeutic Revenue and Growth Rate (2011-2021)
Table Global Alzheimer’s Therapeutic Sales of Key Manufacturers (2015 and 2016)
Table Global Alzheimer’s Therapeutic Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Alzheimer’s Therapeutic Sales Share by Manufacturers
Figure 2016 Alzheimer’s Therapeutic Sales Share by Manufacturers
Table Global Alzheimer’s Therapeutic Revenue by Manufacturers (2015 and 2016)
Table Global Alzheimer’s Therapeutic Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Alzheimer’s Therapeutic Revenue Share by Manufacturers
Table 2016 Global Alzheimer’s Therapeutic Revenue Share by Manufacturers
Table Manufacturers Alzheimer’s Therapeutic Manufacturing Base Distribution and Product Type
Table Global Alzheimer’s Therapeutic Sales Market by Region (2011-2021)
Figure Global Alzheimer’s Therapeutic Sales Market by Region (2011-2021)
Figure Global Alzheimer’s Therapeutic Sales Market Share by Region (2011-2021)
Table Global Alzheimer’s Therapeutic Revenue Market by Region (2011-2021)
Table Global Alzheimer’s Therapeutic Revenue Market Share by Region (2011-2021)
Table North America Alzheimer’s Therapeutic Sales, Revenue and Price (2011-2021)
Figure North America Alzheimer’s Therapeutic Sales, Revenue and Growth Rate (2011-2021)
Table Europe Alzheimer’s Therapeutic Sales, Revenue and Price (2011-2021)
Figure Europe Alzheimer’s Therapeutic Sales, Revenue and Growth Rate (2011-2021)
Table China Alzheimer’s Therapeutic Sales, Revenue and Price (2011-2021)
Figure China Alzheimer’s Therapeutic Sales, Revenue and Growth Rate (2011-2021)
Table Japan Alzheimer’s Therapeutic Sales, Revenue and Price (2011-2021)
Figure Japan Alzheimer’s Therapeutic Sales, Revenue and Growth Rate (2011-2021)
Table India Alzheimer’s Therapeutic Sales, Revenue and Price (2011-2021)
Figure India Alzheimer’s Therapeutic Sales, Revenue and Growth Rate (2011-2021)
Table Southeast Asia Alzheimer’s Therapeutic Sales, Revenue and Price (2011-2021)
Figure Southeast Asia Alzheimer’s Therapeutic Sales, Revenue and Growth Rate (2011-2021)
Table Global Alzheimer’s Therapeutic Sales by Type (2011-2021)
Table Global Alzheimer’s Therapeutic Sales Share by Type (2011-2021)
Figure Sales Market Share of Alzheimer’s Therapeutic by Type (2011-2021)
Figure Global Alzheimer’s Therapeutic Sales Growth Rate by Type (2011-2021)
Table Global Alzheimer’s Therapeutic Revenue by Type (2011-2021)
Table Global Alzheimer’s Therapeutic Revenue Share by Type (2011-2021)
Figure Global Alzheimer’s Therapeutic Revenue Growth Rate by Type (2011-2021)
Figure Memantine Hydrochloride Sales, Revenue and Growth (2011-2021)
Figure Memantine Hydrochloride Price Trend (2011-2021)
Figure Donepezil Hydrochloride Sales, Revenue and Growth (2011-2021)
Figure Donepezil Hydrochloride Price Trend (2011-2021)
Figure Rivastigmine Sales, Revenue and Growth (2011-2021)
Figure Rivastigmine Price Trend (2011-2021)
Figure Galantamine Hydrobromide Sales, Revenue and Growth (2011-2021)
Figure Galantamine Hydrobromide Price Trend (2011-2021)
Table Global Alzheimer’s Therapeutic Sales by Application (2011-2021)
Table Global Alzheimer’s Therapeutic Sales Market Share by Application (2011-2021)
Figure Global Alzheimer’s Therapeutic Sales Market Share by Application in 2015
Figure Global Alzheimer’s Therapeutic Sales Market Share by Application in 2021
Table North America Alzheimer’s Therapeutic Sales by Application (2015 and 2016)
Table Europe Alzheimer’s Therapeutic Sales by Application (2015 and 2016)
Table China Alzheimer’s Therapeutic Sales by Application (2015 and 2016)
Table Japan Alzheimer’s Therapeutic Sales by Application (2015 and 2016)
Table India Alzheimer’s Therapeutic Sales by Application (2015 and 2016)
Table Southeast Asia Alzheimer’s Therapeutic Sales by Application (2015 and 2016)
Table Global Alzheimer’s Therapeutic Sales Growth Rate by Application (2011-2021)
Figure Global Alzheimer’s Therapeutic Sales Growth Rate by Application (2011-2021)
Table Pfizer Inc Basic Information List
Table Alzheimer’s Therapeutic Sales, Revenue, Price of Pfizer Inc (2015 and 2016)
Table Novartis International AG Basic Information List
Table Alzheimer’s Therapeutic Sales, Revenue, Price of Novartis International AG (2015 and 2016)
Table Axovant Sciences Ltd Basic Information List
Table Alzheimer’s Therapeutic Sales, Revenue, Price of Axovant Sciences Ltd (2015 and 2016)
Table Acadia Pharmaceuticals, Inc Basic Information List
Table Alzheimer’s Therapeutic Sales, Revenue, Price of Acadia Pharmaceuticals, Inc (2015 and 2016)
Table Biotie Therapies Basic Information List
Table Alzheimer’s Therapeutic Sales, Revenue, Price of Biotie Therapies (2015 and 2016)
Table Astra Zeneca plc Basic Information List
Table Alzheimer’s Therapeutic Sales, Revenue, Price of Astra Zeneca plc (2015 and 2016)
Table Eli Lilly, Inc Basic Information List
Table Alzheimer’s Therapeutic Sales, Revenue, Price of Eli Lilly, Inc (2015 and 2016)
Table F. Hoffman Le Roche Basic Information List
Table Alzheimer’s Therapeutic Sales, Revenue, Price of F. Hoffman Le Roche (2015 and 2016)
Table Merck & Co Basic Information List
Table Alzheimer’s Therapeutic Sales, Revenue, Price of Merck & Co (2015 and 2016)
Table H. Lundbeck A/S Basic Information List
Table Alzheimer’s Therapeutic Sales, Revenue, Price of H. Lundbeck A/S (2015 and 2016)
Table Takeda Pharmaceutical Company Ltd Basic Information List
Table Alzheimer’s Therapeutic Sales, Revenue, Price of Takeda Pharmaceutical Company Ltd (2015 and 2016)